1-deoxynojirimycin has been researched along with Insulin Sensitivity in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.26) | 18.2507 |
| 2000's | 5 (26.32) | 29.6817 |
| 2010's | 7 (36.84) | 24.3611 |
| 2020's | 6 (31.58) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, Y; Han, A; He, L; Jia, Q; Ren, X; Xing, Y; Xiu, Z; Yang, L | 1 |
| Ampawong, S; Aramwit, P; Fongsodsri, K; Kanjanapruthipong, T; Reamtong, O; Rujimongkon, K; Thaipitakwong, T | 1 |
| Dai, P; Hou, J; Ji, X; Jin, C; Liu, N; Song, Z; Wen, F | 1 |
| Dong, Y; Guo, Q; Han, X; He, X; Jiang, H; Liu, H; Ren, X; Xiu, Z | 1 |
| Chai, T; Du, HY; Jiang, Y; Li, L; Xu, H; Zhang, Y | 1 |
| Honda, Y; Imajo, K; Iwaki, M; Kessoku, T; Kobayashi, T; Nagashima, Y; Nakajima, A; Nogami, A; Ogawa, Y; Ozaki, A; Saito, S; Tomeno, W; Yoneda, M | 1 |
| Kishida, Y; Ohno, H; Oki, K; Okubo, H; Yoneda, M | 1 |
| Kim, SS; Koide, M; Nagasawa, Y; Sawada, T; Shiotani, H; Terashita, D; Yokoyama, M | 1 |
| Ji, DF; Li, YG; Lin, TB; Lv, ZQ; Zhong, S | 1 |
| Li, C; Li, X; Liu, Q; Peng, G; Zheng, Y | 1 |
| Li, C; Li, H; Li, X; Liu, Q; Peng, G; Wang, F; Zheng, Y | 1 |
| Aerts, JM; Arbeeny, C; Aten, J; Bijl, N; Dubbelhuis, PF; Ghauharali-van der Vlugt, K; Groen, AK; Ottenhoff, R; Overkleeft, HS; Seeman, I; van Eijk, M; van Roomen, CP | 1 |
| Aerts, JM; Aten, J; Bijl, N; Boot, RG; Claessen, N; Groen, AK; Langeveld, M; Moerland, PD; Ottenhoff, R; Sokolović, M; van Eijk, M; van Roomen, CP; Vrins, C | 1 |
| Aerts, JM; Aten, J; Bietrix, FM; Bijl, N; Boot, RG; Dekker, N; Groen, AK; Groener, J; Langeveld, M; Lombardo, E; Ottenhoff, R; Overkleeft, HS; Serlie, M; van Eijk, M; van Roomen, C; Wennekes, T | 1 |
| Fuchigami, M; Furuta, S; Hamada, Y; Nagasaki, H; Nakamura, J; Oiso, Y; Seino, Y | 1 |
| Fischer, S; Hanefeld, M | 1 |
| Ahn, YR; Kim, JH; Kim, KW; Kong, WH; Oh, SH; Seo, SW | 1 |
| Dolphin, PJ; Graham, SE; Russell, JC | 1 |
| Fehmann, HC | 1 |
1 review(s) available for 1-deoxynojirimycin and Insulin Sensitivity
| Article | Year |
|---|---|
Glycosphingolipids and insulin resistance.
Topics: 1-Deoxynojirimycin; Adamantane; Animals; Cardiovascular Diseases; Ceramides; Diabetes Mellitus, Type 2; Dioxanes; Disease Models, Animal; Fatty Acids; Fatty Liver; Gaucher Disease; Glucosyltransferases; Glycosphingolipids; Humans; Insulin Resistance; Metabolic Syndrome; Mice; Mice, Obese; Non-alcoholic Fatty Liver Disease; Obesity; Pyrrolidines; Receptor, Insulin; Signal Transduction | 2011 |
2 trial(s) available for 1-deoxynojirimycin and Insulin Sensitivity
| Article | Year |
|---|---|
Comparison of effects of α-Glucosidase inhibitors and glinide drugs on endothelial dysfunction in diabetic patients with coronary artery disease.
Topics: 1-Deoxynojirimycin; Aged; Aged, 80 and over; Coronary Artery Disease; Cyclohexanes; Diabetic Angiopathies; Dyslipidemias; Endothelium, Vascular; Enzyme Inhibitors; Female; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin Resistance; Lipids; Male; Middle Aged; Nateglinide; Phenylalanine | 2014 |
[Alpha-glucosidase inhibitor for type 2 diabetic patients. Clinical study with miglitol].
Topics: 1-Deoxynojirimycin; Diabetes Mellitus, Type 2; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Imino Pyranoses; Insulin Resistance | 2000 |
16 other study(ies) available for 1-deoxynojirimycin and Insulin Sensitivity
| Article | Year |
|---|---|
Effect of 1-Deoxynojirimycin on insulin resistance in prediabetic mice based on next-generation sequencing and intestinal microbiota study.
Topics: 1-Deoxynojirimycin; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Progression; Gastrointestinal Microbiome; High-Throughput Nucleotide Sequencing; Insulin Resistance; Lipid Metabolism; Male; Mice; Mice, Inbred C57BL; Morus; Prediabetic State; Streptozocin | 2022 |
Mulberry-Derived 1-Deoxynojirimycin Prevents Type 2 Diabetes Mellitus Progression via Modulation of Retinol-Binding Protein 4 and Haptoglobin.
Topics: 1-Deoxynojirimycin; Diabetes Mellitus, Type 2; Haptoglobins; Humans; Inflammation; Insulin Resistance; Morus; Plant Extracts; Plant Leaves; Powders; Prediabetic State | 2022 |
Alleviating effect of mulberry leaf 1-deoxynojirimycin on resistin-induced hepatic steatosis and insulin resistance in mice.
Topics: 1-Deoxynojirimycin; Animals; Fatty Liver; Insulin; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Morus; Plant Leaves; Resistin | 2022 |
Combinational application of the natural products 1-deoxynojirimycin and morin ameliorates insulin resistance and lipid accumulation in prediabetic mice.
Topics: 1-Deoxynojirimycin; Animals; Diabetes Mellitus, Type 2; Drug Combinations; Flavonoids; Insulin; Insulin Resistance; Lipids; Mice; PPAR gamma; Prediabetic State | 2023 |
Mulberry leaf multi-components exert hypoglycemic effects through regulation of the PI-3K/Akt insulin signaling pathway in type 2 diabetic rats.
Topics: 1-Deoxynojirimycin; Adipokines; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucose; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipids; Morus; Phosphatidylinositol 3-Kinases; Plant Leaves; Polysaccharides; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction | 2024 |
Protective effect of SGL5213, a potent intestinal sodium-glucose cotransporter 1 inhibitor, in nonalcoholic fatty liver disease in mice.
Topics: 1-Deoxynojirimycin; Animals; Chronic Disease; Diet, High-Fat; Dietary Sucrose; Disease Models, Animal; Gastrointestinal Absorption; Gene Expression; Glucose; Insulin Resistance; Male; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity; Patient Acuity; RNA, Messenger; Sodium-Glucose Transporter 1; Sorbitol | 2021 |
Effect of miglitol on the suppression of nonalcoholic steatohepatitis development and improvement of the gut environment in a rodent model.
Topics: 1-Deoxynojirimycin; Animals; Diet, High-Fat; Disease Models, Animal; Gastrointestinal Microbiome; Glucagon-Like Peptide 1; Glycoside Hydrolase Inhibitors; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease | 2017 |
Hypoglycemic effect of deoxynojirimycin-polysaccharide on high fat diet and streptozotocin-induced diabetic mice via regulation of hepatic glucose metabolism.
Topics: 1-Deoxynojirimycin; Animals; Blood Glucose; Blotting, Western; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Fructose-Bisphosphatase; Glucokinase; Glucosamine; Glucose-6-Phosphatase; Hypoglycemic Agents; Insulin Resistance; Liver; Male; Mice; Mice, Inbred ICR; Phosphoenolpyruvate Carboxykinase (ATP); Phosphofructokinase-1, Liver Type; Pyruvate Carboxylase; Pyruvate Decarboxylase; Random Allocation | 2015 |
1-Deoxynojirimycin Alleviates Insulin Resistance via Activation of Insulin Signaling PI3K/AKT Pathway in Skeletal Muscle of db/db Mice.
Topics: 1-Deoxynojirimycin; Animals; Diabetes Mellitus, Type 2; Drug Evaluation, Preclinical; Glucose Transporter Type 4; Hypoglycemic Agents; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Male; Mice, Inbred C57BL; Mice, Mutant Strains; Morus; Muscle, Skeletal; Phosphatidylinositol 3-Kinases; Phosphorylation; Plant Extracts; Plant Leaves; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Signal Transduction | 2015 |
1-Deoxynojirimycin Alleviates Liver Injury and Improves Hepatic Glucose Metabolism in db/db Mice.
Topics: 1-Deoxynojirimycin; Animals; Dose-Response Relationship, Drug; Fatty Liver; Glucose; Hypoglycemic Agents; Injections, Intravenous; Insulin Resistance; Lipid Metabolism; Liver; Male; Mice; Mice, Transgenic; Molecular Structure; Signal Transduction | 2016 |
Reducing glycosphingolipid content in adipose tissue of obese mice restores insulin sensitivity, adipogenesis and reduces inflammation.
Topics: 1-Deoxynojirimycin; Adamantane; Adipogenesis; Adiponectin; Adipose Tissue; Animals; Chemokine CCL2; Glucose; Glycosphingolipids; Homeostasis; Inflammation; Insulin Resistance; Macrophages; Mice; Mice, Inbred C57BL; Mice, Obese; Signal Transduction | 2009 |
Modulation of glycosphingolipid metabolism significantly improves hepatic insulin sensitivity and reverses hepatic steatosis in mice.
Topics: 1-Deoxynojirimycin; Adamantane; Animals; Disease Models, Animal; Fatty Liver; Glucose; Glycosphingolipids; Homeostasis; Insulin; Insulin Resistance; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Triglycerides | 2009 |
The alpha-glucosidase inhibitor miglitol affects bile acid metabolism and ameliorates obesity and insulin resistance in diabetic mice.
Topics: 1-Deoxynojirimycin; Animals; Bile Acids and Salts; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Drug Evaluation, Preclinical; Enzyme Inhibitors; Glycoside Hydrolase Inhibitors; Hep G2 Cells; Humans; Hypoglycemic Agents; Insulin Resistance; Male; Mice; Obesity; Rats; Rats, Wistar | 2013 |
[Therapy decision based on the glucose triad. Drug treatment of type 2 diabetes].
Topics: 1-Deoxynojirimycin; Acarbose; Administration, Oral; Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Fasting; Glucosamine; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Imino Pyranoses; Insulin; Insulin Resistance; Insulin Secretion; Metformin; Obesity; Pioglitazone; Risk Factors; Rosiglitazone; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones; Time Factors | 2003 |
Antiobesity effects and improvement of insulin sensitivity by 1-deoxynojirimycin in animal models.
Topics: 1-Deoxynojirimycin; Animals; Anti-Obesity Agents; Blood Glucose; Bombyx; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Glucose Tolerance Test; Glycoside Hydrolase Inhibitors; Insulin; Insulin Resistance; Male; Rats; Rats, Inbred OLETF; Rats, Sprague-Dawley; Weight Gain | 2008 |
Glucose tolerance and insulin resistance in the JCR:LA-corpulent rat: effect of miglitol (Bay m1099).
Topics: 1-Deoxynojirimycin; Animals; Blood Glucose; Body Weight; Disease Models, Animal; Eating; Enzyme Inhibitors; Glucosamine; Glucose Tolerance Test; Glycoside Hydrolase Inhibitors; Hypoglycemic Agents; Imino Pyranoses; Insulin; Insulin Resistance; Lipids; Male; Obesity; Postprandial Period; Rats | 1999 |